News
Irvine, California-based Edwards triggered the agreement to repurchase $500 million of its common stock. With this ...
Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company developing innovative combination therapies for high-impact conditions, today ...
Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $500 million of Edwards’ common stock. With this transaction, ...
1d
TipRanks on MSNBrightstar Lottery PLC Completes Significant Share Repurchase
Brightstar Lottery ( ($BRSL) ) has shared an announcement. On August 6, 2025, Brightstar Lottery PLC repurchased 13,573,035 of its ordinary shares ...
Kemper Corporation (NYSE: KMPR) announced today that it has entered into an accelerated share repurchase transaction ("ASR") ...
United Therapeutics will repurchase these shares under the $1 billion repurchase program authorized by the company’s board of directors and previously announced on July 30, 2025.
WESTMINSTER, Colo., June 16, 2025 /PRNewswire/ -- Ball Corporation (NYSE: BALL) announced today an agreement to repurchase approximately $250 million of its outstanding common stock in a privately ...
Final settlement of the Collared accelerated share repurchase agreement is expected to be in the first quarter of 2026. UTHR +6.11% premarket to $291.5 Source: Press Release ...
Leerink Partners analyst Michael Cherny maintained Premier with a Market Perform and raised the price target from $24 to $26. B of A Securities analyst Michael Cherny maintained the stock with an ...
The accelerated stock buyback is part of the $750 million share repurchase authorization approved by CACI’s board of directors on Thursday, Jan. 26.
--Ball Corporation announced today an agreement to repurchase approximately $250 million of its outstanding common stock in a privately negotiated, accelerated stock repurchase transaction with ...
3d
TipRanks on MSNEdwards Lifesciences announces $500M accelerated share repurchase
Edwards Lifesciences (EW) announced that it has executed an accelerated share repurchase agreement repurchase $500M of Edwards’ common stock. With ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results